RMTI Financial Facts

Cost of Sales: 11.23M
Operating Income (Loss): -4.75M
See Full Income Statement

Cash and Cash Equivalents: 19.29M
Total Liabilities and Shareholders' Equity: 82.85M
See Full Balance Sheet

Rockwell Medical (RMTI) Earnings

  |   Expand Research on RMTI
Next EPS Date 11/16/26 EPS Growth Rate N/A
Average EPS % Beat Rate +68.3% Revenue Growth Rate +14.9%
Average % Move 1-Wk after EPS -6.7% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/16/26 Q326 N/A-$0.18 N/A N/A$18.27M = N/A N/A
8/13/26 Q226 -$0.04-$0.03 -$0.01$17.78M$17.84M = Details
5/7/26 Q126 -$0.01-$0.03 +$0.02$17.3M$17.95M = Details
3/26/26 Q425 $0.02-$0.05 +$0.07$18.3M$16.53M = Details
11/12/25 Q325 $0.00-$0.05 +$0.05$15.9M$16.18M = Details
8/14/25 Q225 -$0.01-$0.05 +$0.04$16.1M$16.33M = Details
5/12/25 Q125 -$0.01-$0.04 +$0.03$18.9M$19.14M = Details
3/20/25 Q424 $0.04$0.00 +$0.04$24.7M$24.07M = Details